Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I
and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.
本发明涉及腈基衍
生物及包含腈基衍
生物的制药组合物。所述制药组合物包括式I化合物及其药学上可接受的盐。本发明还涉及制备该类化合物的方法、用于制备该类化合物的中间体以及该类化合物在治疗过度增殖性疾病、炎症性疾病和病毒和细菌感染以及诱导癌细胞凋亡中的用途。